임상시험 공급 및 물류 시장 예측(2025-2030년)

The Clinical Trial Supply And Logistics Market is expected to increase from USD 5.310 billion in 2025 to USD 7.538 billion in 2030, with a 7.26% CAGR.

The global clinical trial supply and logistics market is set to experience robust growth, driven by the escalating demand for advanced drug development and the increasing complexity of diseases. Clinical trials, critical for assessing drug safety, require specialized equipment and logistics support to ensure accurate outcomes. Service providers in this market supply essential resources, manage trial sites, and facilitate patient interactions, playing a pivotal role in the research process. The market is propelled by rising disease prevalence and the need for innovative treatments, though high initial costs and the need for a skilled workforce pose barriers to new entrants, fostering intense competition among established players.

Market Drivers

Surge in Drug Research Investments

The increasing investment in drug research is a primary driver of the clinical trial supply and logistics market. Pharmaceutical companies and venture capitalists are funding clinical trials to address the growing complexity and incidence of diseases. This surge in research activities necessitates reliable supply chains for high-quality equipment and materials, directly boosting market demand. The expansion of drug development projects globally underscores the need for efficient logistics to deliver supplies in the right quantity, quality, and timeframe, ensuring seamless trial execution. The focus on developing novel drugs to combat emerging health challenges further amplifies the market's growth prospects during the forecast period.

Lack of Substitutes Enhances Market Position

The absence of viable substitutes strengthens the position of vendors in the clinical trial supply and logistics market. While some pharmaceutical companies may consider managing supply chains in-house, the high costs and risks associated with ensuring timely and quality-compliant deliveries deter such efforts. The emphasis on cost reduction and risk mitigation has driven drug developers to rely on specialized logistics providers, who offer expertise and infrastructure tailored to clinical trial needs. This lack of alternatives grants suppliers significant market power, enabling them to maintain a competitive edge and capitalize on the growing demand for outsourced logistics solutions.

Geographical Outlook

The North American and European markets are expected to dominate the global clinical trial supply and logistics industry, primarily due to the high concentration of pharmaceutical research organizations in these regions. Their advanced infrastructure, regulatory frameworks, and significant R&D investments create a conducive environment for market growth. Meanwhile, the Asia Pacific region is projected to experience rapid expansion, driven by increasing pharmaceutical research activities and improving healthcare infrastructure. The region's growth is further supported by rising investments and favorable policies, positioning it as a key contributor to the global market.

Market Outlook

The clinical trial supply and logistics market is poised for significant expansion through 2030, fueled by heightened drug research investments and the absence of substitute solutions. North America and Europe will lead due to their robust pharmaceutical ecosystems, while the Asia Pacific region emerges as a high-growth market. Despite challenges like high entry barriers and workforce skill requirements, the market's competitive landscape and critical role in drug development ensure strong growth prospects. Stakeholders must focus on innovation and scalability to meet the evolving demands of global clinical research.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Service Type

• Manufacturing
• Packaging & Labeling
• Storing
• Others

By Clinical Phase

• Phase 1
• Phase 2
• Phase 3
• Phase 4

By Application

• Oncology
• Cardiology
• Respiratory Disease
• CNS & Mental Disorders
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organization (CRO)
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY SERVICE TYPE

• 5.1. Introduction
• 5.2. Manufacturing
• 5.3. Packaging & Labeling
• 5.4. Storing
• 5.5. Others

6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY CLINICAL PHASE

• 6.1. Introduction
• 6.2. Phase 1
• 6.3. Phase 2
• 6.4. Phase 3
• 6.5. Phase 4

7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Oncology
• 7.3. Cardiology
• 7.4. Respiratory Disease
• 7.5. CNS & Mental Disorders
• 7.6. Others

8. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Contract Research Organization (CRO)
• 8.4. Others

9. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Italy
  • 9.4.5. Spain
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Israel
  • 9.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Taiwan
  • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. DHL International GmbH
• 11.2. Marken
• 11.3. Parexel International Corporation
• 11.4. Movianto
• 11.5. Catalent Inc.
• 11.6. Thermo Fisher Scientific Inc.
• 11.7. Almac Group
• 11.8. FedEx
• 11.9. PCI Pharma Service
• 11.10. Sharp Services, LLC

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations